COJOCARU, S.; RUSSU, I.; BUTA, G.; BERSAN, S.; POTÎNG-RAȘCOV, V.; CULIUC, N.; BABA, L. A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease. One Health & Risk Management , v. 4, n. 4, p. 19-26, 29 Sep. 2023.